- Last Updated on Sunday, 03 January 2016 08:03
University of California, San Francisco (UCSF) and PHI collaborate to accelerate skin cancer research utilizing PHI’s proprietary label-free holographic imaging cytometry technology. The program focus on establishing the best practices and validating the most useful HoloMonitor M4 parameters for simultaneous detection of changes in proliferation, cell death and motility in primary human melanomas and cultured melanocytes. Read more at PRNewswire
Dr. Robert Judson
Dr. Judson earned his Ph.D. in Biomedical Sciences from UCSF in the laboratory of Dr. Robert Blelloch developing techniques of high-throughput high-content imaging to study microRNA target genetic interactions during somatic cell reprogramming. After further post-doctoral training with Dr. Boris Bastian, Dr. Judson was awarded the NIH Early Independence Award and now heads a research group in the Helen Diller Comprehensive Cancer Center as a UCSF Sandler Faculty Fellow, where his group is establishing novel models of melanoma subtypes and using a variety of techniques to study the genetic interactions that govern disease progression.